Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Understanding Riverine Nitrogen Impacts and Primary Productivity for Effective Nutrient Management
Published on: July 14, 2023
Sociodemographic Characteristics and Drug Use Practices Associated with Fentanyl Use Frequency Among People Who Use
Evelyn Lai1, Katie B Biello1,2,3, Jane A Buxton4,5
1Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.
Background:
Since 2013, fentanyl has dominated unregulated drug supplies in the northeast and has become a key driver of overdose deaths. In this analysis, we sought to identify the characteristics associated with fentanyl use frequency among people who use drugs in Rhode Island.
Methods:
We examined baseline data from the Rhode Island Prescription and Illicit Drug Study, which enrolled participants from August 2020 to February 2023. We used an ordinal logistic regression to identify sociodemographic and drug use characteristics that were associated with prior month fentanyl use frequency, which was categorized as none, less than weekly, or at least weekly.
Results:
Among 471 participants, 210 (44%) reported no prior month use of fentanyl or drugs containing fentanyl, 121 (26%) reported less than weekly use, and 140 (30%) reported at least weekly use. Of those who reported at least weekly use, 74% reported intentional use. In bivariate analyses, the proportion of participants utilizing harm reduction practices (e.g., fentanyl test strip use, naloxone carriage) increased with fentanyl use frequency in a dose-response manner. In adjusted analyses, prior month injection drug use, fentanyl preference, regular use of crack cocaine, lifetime overdose history, and current enrollment in opioid agonist therapy were significantly associated (p 0.05) with greater fentanyl use frequency.
Conclusions:
Fentanyl exposure and intentional fentanyl use were common in the sample. Our findings suggest a need for increased investment in community-based harm reduction services and low-barrier, patient-centered treatment for polysubstance use, including those involving stimulant use disorders.
More Related Videos
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Characteristics of Practical Op Amps
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Drug Interactions
Bioequivalence of Drugs: Drugs with Multiple Indications
FDA Approved Drugs: Changes to Approved Drugs